Neuropsychiatric Disease and Treatment (Sep 2023)
Serum Levels of Tumor Necrosis Factor-α and Vascular Endothelial Growth Factor in the Subtypes of Clinical High Risk Individuals: A Prospective Cohort Study [Letter]
Abstract
Lisa Andriani Lienggonegoro,* Frans Dany,* Novaria Sari Dewi Panjaitan* Center for Biomedical Research, Research Organization for Health, National Research and Innovation Agency (BRIN), Cibinong Science Center, Cibinong, West Java, Indonesia*These authors contributed equally to this workCorrespondence: Lisa Andriani Lienggonegoro, Center for Biomedical Research, Research Organization for Health, National Research and Innovation Agency (BRIN), Genomic Building, Cibinong Science Center, Jalan Raya Bogor Km. 46, Cibinong, West Java, 16911, Indonesia, Email [email protected]